Page last updated: 2024-08-24
valsartan and Uterine Neoplasms
valsartan has been researched along with Uterine Neoplasms in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ernst, MT; Hallas, J; Johansen, NB; Kristensen, KB; Pottegård, A; Quartarolo, P | 1 |
Other Studies
1 other study(ies) available for valsartan and Uterine Neoplasms
Article | Year |
---|---|
Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cohort Studies; Colorectal Neoplasms; Denmark; Dimethylnitrosamine; Drug Contamination; Female; Humans; Male; Middle Aged; Neoplasms; Risk Factors; Uterine Neoplasms; Valsartan | 2018 |